TCRX · TScan Therapeutics, Inc. · Executive Compensation
$0.18
-0.01 (-4.64%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Market Cap
$12.48M
Shares
67.78M
Volume · Oct 28
171.1K
Avg daily vol (3M)
746.59K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gavin MacBeath | Chief Executive Officer and Director | $2,801,450 |
| Chrystal Louis | M.D., M.P.H. Chief Medical Officer | $1,609,600 |
| Jason A. Amello | Chief Financial Officer and Treasurer | $1,275,995 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jason A. Amello | Chief Financial Officer and Treasurer | $3,733,892 |
| Chrystal Louis | M.D., M.P.H. Chief Medical Officer | $3,030,461 |
| Gavin MacBeath | Chief Executive Officer and Director | $1,760,671 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gavin MacBeath | Chief Executive Officer and Director | $3,196,054 |
| Debora Barton | Former Chief Medical Officer | $1,709,996 |
| Brian Silver | Former Chief Financial Officer and Treasurer | $1,584,172 |
| Zoran Zdraveski | J.D., Ph.D. Chief Legal and Strategy Officer and Secretary | $1,581,766 |
| David Southwell | Former President, Chief Executive Officer and Director | $1,292,446 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Southwell | Former President, Chief Executive Officer and Director | $2,142,743 |
| Brian Silver | Former Chief Financial Officer and Treasurer | $1,601,123 |
| Gavin MacBeath | Chief Executive Officer and Director | $1,361,727 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Brian Silver | Chief Financial Officer and Treasurer | $3,182,986 |
| David Southwell | Former President, Chief Executive Officer and Director | $2,807,486 |
| Gavin MacBeath | Acting Chief Executive Officer, Chief Scientific and Operating Officer | $1,189,840 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Southwell | President, Chief Executive Officer and Director | $750,238 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| R. Keith Woods | Nominating and Corporate Governance Committee chairperson | Appointed | 2026-10-16 |
| Stephen Biggar | Nominating and Corporate Governance Committee member | Appointed | 2026-10-16 |
| Gabriela Gruia, M.D. | Board of Directors | Resigned | 2026-10-16 |
| Garry Nicholson | Board of Directors | Resigned | 2026-10-16 |
| Jason A. Amello | Chief Financial Officer | Terminated | 2026-09-30 |
| Gavin MacBeath | principal financial officer and principal accounting officer | Appointed | 2026-09-02 |
| Chrystal Louis | Chief Medical Officer | Terminated | 2026-09-02 |
| Jason A. Amello | Chief Financial Officer | Terminated | 2026-09-02 |
| Jason A. Amello | principal accounting officer | Appointed | 2026-04-02 |
| Leiden Dworak | Principal Accounting Officer | Appointed | 2025-08-20 |
| Garry A. Nicholson | Board of Directors | Appointed | 2024-06-14 |
| Stephen Biggar | Chairman of the Board | Appointed | 2024-06-14 |
| Timothy Barberich | Chairman of the Board | Resigned | 2024-06-14 |
| Jason A. Amello | principal accounting officer | Appointed | 2024-01-29 |
| Jason A. Amello | Chief Financial Officer | Appointed | 2024-01-29 |
| R. Keith Woods | Class II director | Appointed | 2023-12-07 |
| Leiden Dworak | Principal Accounting Officer | Appointed | 2023-07-25 |
| Brian Silver | Chief Financial Officer | Resigned | 2023-07-25 |
| Brian Silver | Chief Financial Officer and Treasurer | Resigned | 2023-06-29 |
| Katina Dorton | Nominating and Corporate Governance Committee member | Appointed | 2023-06-16 |
| Gabriela Gruia | Nominating and Corporate Governance Committee member | Appointed | 2023-06-16 |
| Barbara Klencke | Audit Committee member | Appointed | 2023-06-16 |
| Gavin MacBeath | Class I director | Appointed | 2023-05-31 |
| Gavin MacBeath | Chief Executive Officer | Appointed | 2023-05-31 |
| Barbara Klencke, M.D. | Class III director | Appointed | 2023-04-10 |
Leadership
- Gavin MacBeath CEO, CFO
- Stephen Biggar Chairman
- Brian Silver CFO
- Jason A. Amello Chief Accounting Officer, Board Member
- Leiden Dworak Chief Accounting Officer
- Barbara Klencke, M.D. Board Member
- Chrystal Louis Board Member
- Garry A. Nicholson Board Member
- Katina Dorton Board Member
- R. Keith Woods Board Member
- Zoran Zdraveski Board Member